Research Options:
Select below
IPO Calendar
Week of Expected Pricing
Withdrawn
Company Name
URIGEN PHARMACEUTICALS, INC.
Proposed Ticker
N/A
CUSIP
N/A
Business Description
Specialize in developing innovative products to ameliorate the cause and symptoms associated with urological ailments, specifically Interstitial Cystitis/Bladder Pain Syndrome (“BPS” or “IC/BPS”).
Lead Underwriter
N/A
Co-Managers
N/A
Initial Shares
N/A
Revised Initial Shares
N/A
Initial Price
N/A
Revised Price
N/A
Final Price
N/A
Final Ticker
N/A
© 2024 ICE Data Services. All rights reserved.
